Wilmington, DE, United States of America

Liangxing Wu

This inventor holds 114 USPTO granted patents and 67 published patent applications, plus 11 CIPO patents and 36 EPO patents, primarily in Heterocyclic Compounds (CPC class C07D471-04). Top assignees: Incyte Corporation, Incyte Holdings Corporation. Active years: 2016-2026.

USPTO Granted Patents = 114 (Patent Applications = 67)

% Patents Active = 99.1

CIPO Patents = 11 (Patent Applications = 27)

EPO Patents = 36 (Patent Applications = 67)

Average Co-Inventor Count = 4.4

ph-index = 24

Forward Citations = 1,425(Granted Patents)

Forward Citations (Not Self Cited) = 628(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Upper Darby, PA (US) (2017)
Wilmington, PA (US) (2017)
Wilmington, DE (US) (2016 - 2024)

Company Filing History:

Incyte Holdings Corporation

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

CDK2 Inhibitors

JAK2 Inhibitors

Immunomodulators

FGFR Inhibitors

A2A Inhibitors

Tricyclic Compounds

Bicyclic Compounds

Pyrazolopyrimidine

Pyrimidine Derivatives

Sting Activators

Urea Compounds

114 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735424 - Fused pyrazine derivatives as A2A / A2B inhibitors (2026-09-15),

2. 12534463 - SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS (2026-01-27),

3. 12516044 - Heterocyclic compounds as immunomodulators (2026-01-06),

4. 12466828 - BICYCLIC AMINES AS CDK2 INHIBITORS (2025-11-11),

5. 12466822 - Heterocyclic compounds as immunomodulators (2025-11-11),

6. 12441731 - Pyrazolopyrimidine compounds and uses thereof (2025-10-14),

7. 12312331 - Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors (2025-05-27),

8. 12247038 - Pyrido[3,2-d]pyrimidine compounds as immunomodulators (2025-03-11),

9. 12247026 - Heterocyclic compounds as immunomodulators (2025-03-11),

10. 12187743 - Heterocyclic compounds as immunomodulators (2025-01-07),

11. 12187725 - Tricyclic urea compounds as JAK2 V617F inhibitors (2025-01-07),

12. 12129267 - Heteroaryl amide compounds as sting activators (2024-10-29),

13. 12060433 - CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy (2024-08-13),

14. 12030889 - Imidazopyridazine and imidazopyridine compounds and uses thereof (2024-07-09),

15. 11999740 - Fused pyrazine derivatives as A2A / A2B inhibitors (2024-06-04),

Title: The Innovative Journey of Inventor Liangxing Wu

Introduction: Liangxing Wu, a talented inventor based in Wilmington, DE (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Liangxing Wu holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology. His most recent patent focuses on developing a cutting-edge smart home system that integrates AI for enhanced security and energy efficiency.

Career Highlights: With a background in engineering and a passion for innovation, Liangxing Wu has had a remarkable career marked by numerous achievements. He has worked with leading tech companies to bring his inventions to life and has been recognized for his creative approach to problem-solving.

Collaborations: Throughout his career, Liangxing Wu has collaborated with top researchers, engineers, and scientists to push the boundaries of technology. His ability to work effectively in multidisciplinary teams has led to the successful development of groundbreaking products that have revolutionized the industry.

Conclusion: Liangxing Wu's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventive spirit continues to inspire others to think outside the box and create solutions that shape the future.